batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. No Swiss surprise for Surface’s former owners 23 April 2024 Pluvicto miss puts pressure on PSMAfore expansion 23 April 2024 Carvykti joins Abecma in EU expansion 22 April 2024 Alecensa gets its first-mover adjuvant label 19 April 2024 Imfinzi holds its own in bile duct cancer 16 April 2024 Tecvayli threatens to eclipse Carvykti 16 April 2024 Regeneron’s double-whammy, courtesy of Roche 15 April 2024 Bristol’s son of Revlimid goes pivotal 12 April 2024 Load More